| Předmět: |
|
| Zdroj: |
Drug Week; 11/15/2024, p1908-1908, 1p |
| Abstrakt: |
Researchers at Qatar University have conducted a study on terlipressin-induced skin necrosis in cirrhotic patients, a rare but serious adverse event that requires further investigation. The study emphasizes the importance of early recognition and prompt intervention to prevent complications and improve patient outcomes. Healthcare providers should exercise caution when prescribing terlipressin to cirrhotic patients, weighing the potential benefits against the risks of this rare adverse event. The study also highlights the need for more research to understand the risk factors associated with terlipressin-induced skin necrosis and develop effective preventive strategies. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
